Nvidia’s CUDA-Q and Norma: Quantum AI in the Race for Drug Discovery
Michael Rivera, Sofia Smith, Abby Tuller
Product #:W48272
Supplier:Ivey
Discipline:Information Systems, Strategy
Setting:South Korea, United States, 2025
Subjects:
Your Price:$10.54
Purchase this material with a free Educator Account and enjoy more benefits:
- Free Educator Copy
- Free Teaching Notes
- Build your coursepack
- Discounted academic price
Learning Objectives
- Analyze the trade-offs between formal strategic partnerships and internal development, particularly in emerging technology domains where uncertainty, speed, and differentiation all matter.
- Evaluate the role of platform control and ecosystem management in sustaining long-term competitive advantage, especially in areas with high switching costs and developer lock-in.
- Explore how quantum computing complements, rather than replaces, graphics processing unit (GPU)–accelerated AI and assess how hybrid architectures reshape innovation in fields such as drug discovery.
- Understand the strategic and operational implications of scaling quantum technologies, including talent, energy demands, reputational risk, and sustainability commitments.